Literature DB >> 1544226

An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies.

M A Hazlewood1, D S Kumararatne, A D Webster, M Goodall, P Bird, M Daha.   

Abstract

Inherited deficiencies of complement components are associated with an increased risk of infection by encapsulated, high grade bacterial pathogens such as Streptococcus pneumoniae, Haemophilus influenzae type b and Neisseria meningitidis. Hence, the levels of antibodies to bacterial capsular polysaccharide antigens were measured using ELISA in 65 patients with inherited deficiencies covering the classical, alternative and terminal components of the complement cascade. Three of the four C3-deficient individuals studied were found to be almost totally deficient in specific anti-pneumococcal capsular polysaccharide (PCP) antibodies. These individuals had a history of recurrent pneumococcal sepsis. While single individuals with C1r, C2 and C1Inh deficiency were found to have low anti-PCP antibody levels, no other group of complement deficiency had significantly reduced anti-PCP antibody levels compared with 100 controls. Antibody levels to the other two polysaccharides were not significantly lower in the patient groups. These findings suggest that C3 may be able to provide a stimulatory signal to promote the production of anti-PCP antibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544226      PMCID: PMC1554319          DOI: 10.1111/j.1365-2249.1992.tb03010.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

Review 2.  T cell : B cell collaboration--the response to polysaccharide antigens.

Authors:  F S Rosen
Journal:  Semin Immunol       Date:  1989-09       Impact factor: 11.130

3.  Homozygous C3 deficiency: detection of C3 by radioimmunoassay.

Authors:  A E Davis; J S Davis; A R Rabson; S G Osofsky; H R Colten; F S Rosen; C A Alper
Journal:  Clin Immunol Immunopathol       Date:  1977-11

4.  Role of complement in induction of the allergic response.

Authors:  M B Pepys
Journal:  Nat New Biol       Date:  1972-05-31

5.  Summary of reported deficiencies.

Authors:  K Rother
Journal:  Prog Allergy       Date:  1986

6.  Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study.

Authors:  R Jefferis; C B Reimer; F Skvaril; G de Lange; N R Ling; J Lowe; M R Walker; D J Phillips; C H Aloisio; T W Wells
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

7.  ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.

Authors:  B M Gray
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

Review 8.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

9.  The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation.

Authors:  P Bird; P J Lachmann
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

10.  Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family.

Authors:  J J Roord; M Daha; W Kuis; H A Verbrugh; J Verhoef; B J Zegers; J W Stoop
Journal:  Pediatrics       Date:  1983-01       Impact factor: 7.124

View more
  9 in total

1.  Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.

Authors:  M Drogari-Apiranthitou; C A Fijen; D Van De Beek; E F Hensen; J Dankert; E J Kuijper
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 2.  Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Authors:  Paul Balmer; Andrew J Cant; Ray Borrow
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

3.  Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.

Authors:  Uwe Schauer; Frank Stemberg; Christian H L Rieger; Wolfgang Büttner; Michael Borte; Simone Schubert; Helga Möllers; Frank Riedel; Udo Herz; Harald Renz; Wilhelm Herzog
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Complement component 3: characterization and association with mastitis resistance in Egyptian water buffalo and cattle.

Authors:  Nermin El-Halawany; Shawky A Abd-El-Monsif; F M Al-Tohamy Ahmed; Lamees Hegazy; Hamdy Abdel-Shafy; Magdy A Abdel-Latif; Yasser A Ghazi; Christiane Neuhoff; Dessie Salilew-Wondim; Karl Schellander
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

5.  IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.

Authors:  Cheng-Lung Ku; Capucine Picard; Melinda Erdös; Axel Jeurissen; Jacinta Bustamante; Anne Puel; Horst von Bernuth; Orchidée Filipe-Santos; Huey-Hsuan Chang; Tatiana Lawrence; Marc Raes; László Maródi; Xavier Bossuyt; Jean-Laurent Casanova
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

Review 6.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Recurrent pneumococcal meningitis in homozygous C3 deficiency.

Authors:  Mehmet Totan
Journal:  Indian J Pediatr       Date:  2002-07       Impact factor: 1.967

8.  The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.

Authors:  M Hazlewood; R Nusrat; D S Kumararatne; M Goodall; C Raykundalia; D G Wang; H J Joyce; A Milford-Ward; M Forte; A Pahor
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

9.  Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency.

Authors:  Chester A Alper; Jianhua Xu; Katherine Cosmopoulos; Brian Dolinski; Rosanne Stein; Gabriel Uko; Charles E Larsen; Devendra P Dubey; Peter Densen; Lennart Truedsson; Gunnar Sturfelt; Anders G Sjöholm
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.